|
Login
Directory:
Add Company
| Your company can benefit
from enhanced listings. Questions? Read our FAQ
first. |
Personalized notification service and newsletter info
| Subscribe (free) to get notified
of new additions. |
Learn more About us and about our Services
Contact us
|
Everlife Pharmaceutical Cancer Drug CDA-II 
|
|
CDA-II specifically antagonizes the cancer specific protein factor that locks methylation enzymes in abnormally active state, which are responsible for most cancer problems.
Activity:
- Manufacturing
Product / Technology type(s) covered:
- Enzymes
- Proteins
Therapeutic targets:
|
|
Company Contact
|
Everlife Pharmaceutical Cancer Drug CDA-II
China
Phone:
FAX:
Website: www.everlife.com.cn
|
|
Markets Covered
a. HeadQuarter:
b. Continent(s) active:
c. Countries active:
Corporate data:
Number of Employees:
Turnover:
Year founded:
|
Suggestion box |
Disclaimer | Privacy
Policy | Rules & Regulations
Copyright© Cofidei, Inc. Page last modified: .
|